|
Brodsky, Alexander S., Xiong, Jinjun, Yang, Dongfang, Schorl, Christoph, Fenton, Mary Anne, Graves, Theresa A., Sikov, William M., Resnick, Murray B., Wang, Yihong.
"Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer." BMC Cancer, vol. 16, no. 1, 2016, pp. 274.
|
|
Varadan, Vinay, Miskimen, Kristy L.S., Parsai, Shikha, Krop, Ian E., Winer, Eric P., Bossuyt, Veerle, Abu-Khalaf, Maysa, Sikov, William, Harris, Lyndsay N.
"Abstract 2836: A discovery and validation set of breast cancer preoperative clinical trials show an increase in immune score upon brief-exposure to trastuzumab (T) and the HER2-enriched subtype predict response to combination chemotherapy and T." Cancer Research, vol. 75, no. 15 Supplement, 2015, pp. 2836-2836.
|
|
Iglesia, Michael D, Vincent, Benjamin G, Serody, Jonathan S, Carey, Lisa A, Barry, William T, Sikov, William M, Hudis, Clifford A, Winer, Eric M, Perou, Charles M.
"Abstract PD1-2: Impact of tumor-infiltrating B-cell clonal diversity on response to neoadjuvant therapy in triple negative and HER2+ breast cancer treated on CALGB (Alliance) 40601 and 40603." Cancer Research, vol. 75, no. 9 Supplement, 2015, pp. PD1-2-PD1-2.
|
|
Sikov, William M.
"Assessing the Role of Platinum Agents in Aggressive Breast Cancers." Current Oncology Reports, vol. 17, no. 2, 2015.
|
|
Kuritzky, Benjamin, Sikov, William M.
"How high a bar to change neoadjuvant therapy for triple-negative breast cancer?." Journal of comparative effectiveness research, vol. 4, no. 4, 2015, pp. 293-296.
|
|
Golshan, Mehra, Cirrincione, Constance T., Sikov, William M., Berry, Donald A., Jasinski, Sara, Weisberg, Tracey F., Somlo, George, Hudis, Clifford, Winer, Eric, Ollila, David W.
"Impact of Neoadjuvant Chemotherapy in Stage II–III Triple Negative Breast Cancer on Eligibility for Breast-conserving Surgery and Breast Conservation Rates." Annals of Surgery, vol. 262, no. 3, 2015, pp. 434-439.
|
